ES2040228T3 - Preparado farmaceutico de emision prolongada. - Google Patents

Preparado farmaceutico de emision prolongada.

Info

Publication number
ES2040228T3
ES2040228T3 ES198787110297T ES87110297T ES2040228T3 ES 2040228 T3 ES2040228 T3 ES 2040228T3 ES 198787110297 T ES198787110297 T ES 198787110297T ES 87110297 T ES87110297 T ES 87110297T ES 2040228 T3 ES2040228 T3 ES 2040228T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
prolonged emission
prolonged
emission
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787110297T
Other languages
English (en)
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ES2040228T3 publication Critical patent/ES2040228T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Abstract

UNA PREPARACION DE MEDICAMENTO CON LIBERACION CONTINUA COMPRENDE UN MEDICAMENTO SOLUBLE EN AGUA, UNA SUSTANCIA LIPIDA Y UN ACEITE COMO SUS COMPONENTES PRINCIPALES. EL NIVEL DE MEDICAMENTO EN LA SANGRE SE MANTIENE A UNA CONCENTRACION PREFERIBLE DURANTE UN LARGO PERIODO DE TIEMPO.
ES198787110297T 1986-07-18 1987-07-16 Preparado farmaceutico de emision prolongada. Expired - Lifetime ES2040228T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61167865A JPH0816066B2 (ja) 1986-07-18 1986-07-18 持続性薬効製剤

Publications (1)

Publication Number Publication Date
ES2040228T3 true ES2040228T3 (es) 1993-10-16

Family

ID=15857516

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787110297T Expired - Lifetime ES2040228T3 (es) 1986-07-18 1987-07-16 Preparado farmaceutico de emision prolongada.

Country Status (13)

Country Link
US (1) US5030455A (es)
EP (1) EP0254978B1 (es)
JP (1) JPH0816066B2 (es)
KR (1) KR960004857B1 (es)
AT (1) ATE71291T1 (es)
CA (1) CA1309656C (es)
DE (1) DE3775850D1 (es)
DK (1) DK174931B1 (es)
ES (1) ES2040228T3 (es)
FI (1) FI96095C (es)
GR (1) GR3003536T3 (es)
NO (1) NO179163C (es)
PH (1) PH25286A (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US4975312A (en) * 1988-06-20 1990-12-04 Foster-Miller, Inc. Multiaxially oriented thermotropic polymer substrate for printed wire board
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
JP2794022B2 (ja) * 1988-11-11 1998-09-03 三生製薬株式会社 ブナゾシン或いはその塩類含有経皮適用製剤
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
GB2263910A (en) * 1992-02-05 1993-08-11 Co Ordinated Drug Dev Direct compression tablet excipient
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
CN1103586C (zh) * 1993-12-13 2003-03-26 里达克药品公司 蔗糖酯－c20－28醇制剂
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
CA2233016C (en) * 1995-09-25 2007-07-17 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
US6417326B1 (en) 1996-04-11 2002-07-09 The University Of British Columbia Fusogenic liposomes
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
KR20030024191A (ko) * 2001-09-17 2003-03-26 주식회사 효성 알칼리 가용성 코폴리에스터 및 이의 제조방법
AU2002351008B2 (en) * 2001-11-30 2007-07-12 Pfizer Products Inc. Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
EP2650065A4 (en) * 2010-12-08 2014-06-04 Aida Eng Ltd METHOD FOR THE PRODUCTION OF HIGH-DEFINED SINTERING PRESSURE RINGS AND DEVICE FOR THEIR PRODUCTION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
US4020159A (en) * 1974-10-08 1977-04-26 Apotheker A. Herbert K.G., Fabrik Pharmazeutischer Praparate Wiesbaden Methods of and medications for treating cardiac disorders by using strophanthin
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
EP0176772B1 (de) * 1984-08-30 1989-03-29 RODISMA Pharmazeutische Produkte GmbH Verfahren zur Retardierung von Vitamin C und E

Also Published As

Publication number Publication date
NO179163C (no) 1996-08-21
DK373187D0 (da) 1987-07-17
CA1309656C (en) 1992-11-03
KR880001301A (ko) 1988-04-22
EP0254978A1 (en) 1988-02-03
DK174931B1 (da) 2004-03-01
PH25286A (en) 1991-04-30
KR960004857B1 (ko) 1996-04-16
DK373187A (da) 1988-01-19
EP0254978B1 (en) 1992-01-08
FI873106A (fi) 1988-01-19
FI96095B (fi) 1996-01-31
NO179163B (no) 1996-05-13
NO872991L (no) 1988-01-19
DE3775850D1 (de) 1992-02-20
FI96095C (fi) 1996-05-10
GR3003536T3 (es) 1993-03-16
JPH0816066B2 (ja) 1996-02-21
JPS6327439A (ja) 1988-02-05
US5030455A (en) 1991-07-09
FI873106A0 (fi) 1987-07-14
ATE71291T1 (de) 1992-01-15
NO872991D0 (no) 1987-07-17

Similar Documents

Publication Publication Date Title
ES2040228T3 (es) Preparado farmaceutico de emision prolongada.
ES2060593T3 (es) Sistema de aporte de farmacos.
NO171145C (no) Fremgangsmaate for fremstilling av en fettemulsjon med et hydrofobt medikament
SE8605515D0 (sv) A liquid dosage form for oral administration of a pharmaceutically active substance
FR2390177A1 (fr) Appareil pour introduire des medicaments dans le corps humain ou dans le corps d'un animal
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
FI924376A0 (fi) Aktivitetsreglerande, elektriskt fungerande anordning foer administrering av laekemedel.
IT1128094B (it) Catetere per la somministrazione en dovenosa intermittente di medicamenti
DE69431533D1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
DK136186D0 (da) Laegemiddelbaerer
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
FI864760A0 (fi) Ihmiskehoon istutettava keinotekoinen rauhanen
MX9203556A (es) Una forma de dosificacion para administrar los farmacos beneficos pseudoefedrina y bromofeniramina.
DE68909409T2 (de) Heilmitteldosierung zur verabreichung an fische.
BR8802589A (pt) Sistema de administracao de drogas transdermico eletrosforetico/eletro-osmotico
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
SE8501312D0 (sv) Etoposide oral dosage form
AR023151A1 (es) Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico
ITRM920084U1 (it) Siringa per iniezioni medicali monouso con dispositivo per la scomparsa dell'ago dopo l'uso.
IT8144004A0 (it) Dispositivo atto a controllare la regolare erogazione di soluzione somministrata al paziente mediante fleboclisi e a segnalare ogni possibile inconveniente

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 254978

Country of ref document: ES